These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 22126861

  • 1. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
    Samejima K, Nakatani K, Suzuki D, Asai O, Sakan H, Yoshimoto S, Yamaguchi Y, Matsui M, Akai Y, Toyoda M, Iwano M, Saito Y.
    Nephron Clin Pract; 2012; 120(1):c1-7. PubMed ID: 22126861
    [Abstract] [Full Text] [Related]

  • 2. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
    Shi SF, Wang SX, Zhang YK, Zhao MH, Zou WZ.
    Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926
    [Abstract] [Full Text] [Related]

  • 3. Expression of DENDRIN in several glomerular diseases and correlation to pathological parameters and renal failure - preliminary study.
    Mizdrak M, Vukojević K, Filipović N, Čapkun V, Benzon B, Durdov MG.
    Diagn Pathol; 2018 Nov 20; 13(1):90. PubMed ID: 30458823
    [Abstract] [Full Text] [Related]

  • 4. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
    da Silva CA, Monteiro MLGDR, Araújo LS, Urzedo MG, Rocha LB, Dos Reis MA, Machado JR.
    PLoS One; 2020 Nov 20; 15(11):e0241745. PubMed ID: 33147279
    [Abstract] [Full Text] [Related]

  • 5. Dystroglycan in the diagnosis of FSGS.
    Giannico G, Yang H, Neilson EG, Fogo AB.
    Clin J Am Soc Nephrol; 2009 Nov 20; 4(11):1747-53. PubMed ID: 19808230
    [Abstract] [Full Text] [Related]

  • 6. Role of fibroblast specific protein 1 expression in the progression of adriamycin-induced glomerulosclerosis.
    Nakatani K, Asai O, Konishi N, Iwano M.
    Biochem Biophys Res Commun; 2021 Aug 27; 567():148-153. PubMed ID: 34153685
    [Abstract] [Full Text] [Related]

  • 7. Podocin and uPAR are good biomarkers in cases of Focal and segmental glomerulosclerosis in pediatric renal biopsies.
    Pereira LHM, da Silva CA, Monteiro MLGDR, Araújo LS, Rocha LP, Reis MBDR, Ramalho FS, Corrêa RRM, Silva MV, Reis MA, Machado JR.
    PLoS One; 2019 Aug 27; 14(6):e0217569. PubMed ID: 31188898
    [Abstract] [Full Text] [Related]

  • 8. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
    Eriguchi M, Yotsueda R, Torisu K, Kawai Y, Hasegawa S, Tanaka S, Noguchi H, Masutani K, Kitazono T, Tsuruya K.
    Am J Physiol Renal Physiol; 2016 Feb 15; 310(4):F322-33. PubMed ID: 26632605
    [Abstract] [Full Text] [Related]

  • 9. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children.
    Srivastava T, Garola RE, Singh HK.
    Kidney Int; 2006 Aug 15; 70(3):529-35. PubMed ID: 16775597
    [Abstract] [Full Text] [Related]

  • 10. Comparison of Glomerular Transcriptome Profiles of Adult-Onset Steroid Sensitive Focal Segmental Glomerulosclerosis and Minimal Change Disease.
    Tong J, Xie J, Ren H, Liu J, Zhang W, Wei C, Xu J, Zhang W, Li X, Wang W, Lv D, He JC, Chen N.
    PLoS One; 2015 Aug 15; 10(11):e0140453. PubMed ID: 26536600
    [Abstract] [Full Text] [Related]

  • 11. Vangl2, a planar cell polarity molecule, is implicated in irreversible and reversible kidney glomerular injury.
    Papakrivopoulou E, Vasilopoulou E, Lindenmeyer MT, Pacheco S, Brzóska HŁ, Price KL, Kolatsi-Joannou M, White KE, Henderson DJ, Dean CH, Cohen CD, Salama AD, Woolf AS, Long DA.
    J Pathol; 2018 Dec 15; 246(4):485-496. PubMed ID: 30125361
    [Abstract] [Full Text] [Related]

  • 12. AMPK mediates regulation of glomerular volume and podocyte survival.
    Banu K, Lin Q, Basgen JM, Planoutene M, Wei C, Reghuvaran AC, Tian X, Shi H, Garzon F, Garzia A, Chun N, Cumpelik A, Santeusanio AD, Zhang W, Das B, Salem F, Li L, Ishibe S, Cantley LG, Kaufman L, Lemley KV, Ni Z, He JC, Murphy B, Menon MC.
    JCI Insight; 2021 Oct 08; 6(19):. PubMed ID: 34473647
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of C4d expression and staining patterns by immunohistochemistry in renal biopsy samples with focal segmental glomerulosclerosis and minimal change disease.
    Abedi M, Nili F, Dehkhoda F, Abdollahi A, Salarvand S.
    Ann Diagn Pathol; 2024 Jun 08; 70():152281. PubMed ID: 38417352
    [Abstract] [Full Text] [Related]

  • 14. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy.
    Yamaguchi Y, Iwano M, Suzuki D, Nakatani K, Kimura K, Harada K, Kubo A, Akai Y, Toyoda M, Kanauchi M, Neilson EG, Saito Y.
    Am J Kidney Dis; 2009 Oct 08; 54(4):653-64. PubMed ID: 19615802
    [Abstract] [Full Text] [Related]

  • 15. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
    Novelli R, Gagliardini E, Ruggiero B, Benigni A, Remuzzi G.
    Am J Physiol Renal Physiol; 2016 Mar 01; 310(5):F335-41. PubMed ID: 26697986
    [Abstract] [Full Text] [Related]

  • 16. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
    Wagrowska-Danilewicz M, Stasikowska O, Danilewicz M.
    Pol J Pathol; 2006 Mar 01; 57(1):17-21. PubMed ID: 16739878
    [Abstract] [Full Text] [Related]

  • 17. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
    Husain S, Ginawi I, Bashir AI, Kfoury H, Al Johani TE, Hagar H, Raddaoui L, Al Ghonaim M, Alsuwaida A.
    Ultrastruct Pathol; 2018 Mar 01; 42(5):430-439. PubMed ID: 30285525
    [Abstract] [Full Text] [Related]

  • 18. Morphologic Analysis of Urinary Podocytes in Focal Segmental Glomerulosclerosis.
    Shirai Y, Miura K, Yokoyama T, Horita S, Nakayama H, Seino H, Ando T, Shiratori A, Yabuuchi T, Kaneko N, Ishiwa S, Ishizuka K, Hara M, Hattori M.
    Kidney360; 2021 Mar 25; 2(3):477-486. PubMed ID: 35369007
    [Abstract] [Full Text] [Related]

  • 19. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
    Fuchshofer R, Ullmann S, Zeilbeck LF, Baumann M, Junglas B, Tamm ER.
    Histochem Cell Biol; 2011 Sep 25; 136(3):301-19. PubMed ID: 21814837
    [Abstract] [Full Text] [Related]

  • 20. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
    Miura K, Kurihara H, Horita S, Chikamoto H, Hattori M, Harita Y, Tsurumi H, Kajiho Y, Sawada Y, Sasaki S, Igarashi T, Kunishima S, Sekine T.
    Nephrol Dial Transplant; 2013 Dec 25; 28(12):2993-3003. PubMed ID: 24042022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.